CIK 0000200406
- Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221024240
- Phone
- +1 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,947,986
- in 2 filings
Net −$12,947,986. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-12 | Fasolo Peter Exec VP, Chief HR Officer | Option exercise · Performance Share Units | −12,808 | 0 | ||
| 2024-02-12 | Duato Joaquin CEO and Chairman of the Board | Option exercise | +31,351 | 371,972 | ||
| 2024-02-12 | Duato Joaquin CEO and Chairman of the Board | Option exercise | +5,267 | 377,239 | ||
| 2024-02-12 | Duato Joaquin CEO and Chairman of the Board | Shares withheld for taxes | −15,900 | $157.40 | $2.5M | 361,339 |
| 2024-02-12 | Duato Joaquin CEO and Chairman of the Board | Option exercise · Performance Share Units | −31,351 | 0 | ||
| 2024-02-12 | Decker Robert J VP Corporate Controller | Option exercise | +1,637 | 18,994 | ||
| 2024-02-12 | Decker Robert J VP Corporate Controller | Option exercise | +275 | 19,269 | ||
| 2024-02-12 | Decker Robert J VP Corporate Controller | Shares withheld for taxes | −523 | $157.40 | $82K | 18,746 |
| 2024-02-12 | Decker Robert J VP Corporate Controller | Option exercise · Performance Share Units | −1,637 | 0 | ||
| 2024-02-12 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise | +11,826 | 87,026.87 | ||
| 2024-02-12 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise | +1,987 | 89,013.87 | ||
| 2024-02-12 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Shares withheld for taxes | −7,066 | $157.40 | $1.1M | 81,947.87 |
| 2024-02-12 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise · Performance Share Units | −11,826 | 0 | ||
| 2024-02-09 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise | +35,638 | $90.44 | $3.2M | 102,533.87 |
| 2024-02-09 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Shares withheld for taxes | −27,333 | $156.76 | $4.3M | 75,200.87 |
| 2024-02-09 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option exercise · Employee Stock Options (Right to Buy) | −35,638 | $90.44 | $3.2M | 0 |
| 2024-02-09 | Duato Joaquin CEO and Chairman of the Board | Option exercise | +130,969 | $90.44 | $11.8M | 439,283 |
| 2024-02-09 | Duato Joaquin CEO and Chairman of the Board | Shares withheld for taxes | −98,662 | $156.76 | $15.5M | 340,621 |
| 2024-02-09 | Duato Joaquin CEO and Chairman of the Board | Option exercise · Employee Stock Options (Right to Buy) | −130,969 | $90.44 | $11.8M | 0 |
| 2024-02-09 | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals | Option exercise | +59,397 | $90.44 | $5.4M | 200,813 |
Page 31 of 33 · 658 trades